Monoclonal Anti-AMP Antibodies Are Sensitive and Valuable Tools for Detecting Patterns of AMPylation

Dorothea Höpfner1,2, Joel Fauser1,2, Marietta S Kaspers1

  • 1Department of Biochemistry and Signaltransduction, University Medical Center Hamburg-Eppendorf (UKE), Martinistr. 52, 20246 Hamburg, Germany.

Iscience
|December 10, 2020
PubMed

Insights

Researchers developed novel monoclonal anti-adenosine monophosphate (AMP) antibodies. These tools detect AMPylation, a key post-translational modification, aiding in understanding cellular processes and identifying new cancer targets.

Area of Science:

  • Biochemistry and Molecular Biology
  • Immunology
  • Cancer Research

Background:

  • AMPylation is a post-translational modification involving adenosine monophosphate (AMP) attachment.
  • AMPylation plays a crucial role in regulating infection and maintaining cellular homeostasis.
  • There is a growing need for universal tools to study AMPylation due to its emerging significance.

Purpose of the Study:

  • To develop and characterize novel monoclonal antibodies (mAbs) for detecting AMPylation.
  • To assess the performance of these antibodies in various biochemical applications.
  • To explore the AMPylation patterns in cancer cell lines using the developed mAbs.

Main Methods:

  • Generation of three mouse monoclonal anti-AMP antibodies (mAbs).
  • Validation of mAbs using Western blot, ELISA, and Immunoprecipitation (IP).
  • Application of mAbs to analyze AMPylation in diverse cancer cell lines.

Main Results:

  • Developed highly sensitive and specific anti-AMP mAbs capable of protein backbone-independent AMPylation recognition.
  • Demonstrated antibody efficacy in both denatured (Western blot) and native (ELISA, IP) conditions.
  • Revealed a broad and previously undescribed AMPylation pattern across various cancer cell lines.

Conclusions:

  • The novel anti-AMP mAbs are superior tools for studying AMPylation compared to existing methods.
  • These antibodies facilitate new target identification and validation in AMPylation research.
  • The findings advance the understanding of AMPylation's role and its diverse targets, particularly in cancer.

Related Concept Videos